Sign up to save your podcasts
Or
Share Bridging Gaps, Optimizing Treatment in Patients With LC-FAODs
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Bridging Gaps, Optimizing Treatment in Patients With LC-FAODs
Bridging Gaps, Optimizing Treatment in Patients With LC-FAODs episodes
- 10 min
- Optimizing Triheptanoin Therapy
- Clinical safety and efficacy
- Initiation and titration
- Administration considerations
- Individualizing treatment
19 min - Historical Treatment; Introduction of Triheptanoin
- Dietary modification
- MCT supplementation
- Triheptanoin mechanism of action
6 min - Understanding LC-FAODs
- Autosomal recessive inheritance
- Carnitine shuttle
- Newborn screening
- Clinical features
10 min
About Bridging Gaps, Optimizing Treatment in Patients With LC-FAODs
From the publisher's feed
Patients with long-chain fatty oxidation disorders (LC-FAODs) have historically been treated with diet modification and even-carbon medium-chain triglyceride (MCT) supplementation. In this 45-minute,…
case-based, modular activity, Sandra van Calcar, PhD, RD, LD, and Jerry Vockley, MD, PhD, address key topics, including disease presentation, historical treatment, emerging treatment with triheptanoin, and nutritional planning specific to patients with LC-FAODs.